Abstract:The rapid development of a stereoselective route for CXCR7 antagonist ACT-1004-1239 was needed, as the large-scale chromatographic separation of enantiomers was not a viable option for a resupply campaign that targeted >30 kg of API. The key to success was the stereoselective reduction of a chiral enamine derived from inexpensive (S)-α-methylbenzylamine. The reduction showed good selectivity for the desired cis-3R,4S-isomer, and the pure diastereomer (d.r. >98:2) was isolated as its TFA salt. After removal of the ethylbenzyl group and amide coupling with 5-(2,4-difluorophenyl)isoxazole-3-carboxylic acid, the enantiopure cis-3R,4S-amide was isolated. The subsequent epimerization of the 3-position adjacent to the methyl ester turned out to be a formidable challenge, as the standard conditions with NaOMe led to the formation of a thermodynamic mixture of the cis and trans isomers (final ratio of ∼1:4). Therefore, a new procedure was developed in which the methyl ester was transesterified in situ to the isopropyl ester with KOiPr in iPrOH, followed by epimerization to the trans-iPr-ester (final cis:trans ratio 5:95). After saponification with aqueous KOH, the desired trans-3S,4S-acid was isolated in overall 76% yield. After amide coupling and Boc deprotection, the final reductive amination with cyclopropanecarboxaldehyde was also vastly improved. A novel NaBH(OAc)3 solution in DMSO was used for the reaction and cleanly provided the API with high purity after simple aqueous quench without the need for any solvent switches or aqueous workups. As a proof of concept, 240 g of API was produced in house with the novel stereoselective route, which was then also used to produce over 30 kg of GMP material at an external manufacturer for Phase 2 clinical studies.

A SHORT, EFFICIENT SYNTHESIS OF THE NOVEL CHOLINERGIC CHANNEL ACTIVATOR, ABT-418, FROM L-PROLINE

Synthesis technology of 3-n-propyl-2, 4-dihydroxyacetophenone

A Facile Chiral Pool Synthesis of (S)-6-Nitroindoline-2-carboxylic Acid from l-Phenylalanine

ChemInform Abstract: A Short, Efficient Chiral Synthesis of a Novel Cholinergic Channel Activator, ABT‐418 ((s)‐3‐methyl‐5‐(1‐methyl‐2‐pyrrolidinyl)isoxazole), from (s)‐pyroglutamic Acid.

Chiral Pool Synthesis of N-Cbz-Cis-(3r,4r)-3-Methylamino-4-Methylpiperidine from L-Malic Acid

An Efficient Large-Scale Synthesis of a Naphthylacetic Acid CRTH2 Receptor Antagonist

EFFICIENT MULTIGRAM SYNTHESIS OF 3,3-SPIRO-α-PROLINE CONTAINING CHIMERAS

Development of a Scalable, Stereoselective Second-Generation Route for CXCR7 Antagonist ACT-1004-1239 via Chiral Enamine Reduction and a Novel Telescoped Sequence of Transesterification, cis -to- trans Epimerization, and Saponification

Enantioselective Synthesis of (2S,3r)-3-hydroxy-3-methylproline, A Novel Amino Acid Found in Polyoxypeptins

Discovery and Synthesis of Hydroxy-l-Proline Blockers of the Neutral Amino Acid Transporters SLC1A4 (ASCT1) and SLC1A5 (ASCT2)

Development Of A Concise, Scalable Synthesis Of A Ccr1 Antagonist Utilizing A Continuous Flow Curtius Rearrangement

Development of a Scalable Synthesis of Mevidalen (LY3154207), an Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor

Construction of a chiral central nervous system (CNS)-active aminotetralin drug compound based on a synthesis strategy using multitasking properties of (S)-1-phenylethylamine

A Novel Approach to Cholinergic Signaling Modulation: Development and Characterization of ML352, a Novel, Noncompetitive Inhibitor of the Presynaptic Choline Transporter

ω-Transaminase-catalyzed synthesis of ( R )-2-(1-aminoethyl)-4-fluorophenol, a chiral intermediate of novel anti-tumor drugs

Lab-Scale Preparation of a Novel Carbocyclic Chemokine Receptor Antagonist

Large-Scale Synthesis of LPA1-Receptor Antagonist ACT-1016-0707

Synthesis of a 5-((Aryloxy)methyl)-3-(4-(trifluoromethyl)phenyl)[1,2,4]thiadiazole Derivative: A Promising PPARα,δ Agonist

Scalable Synthesis of C5aR1 Antagonist ACT-1014-6470 via N 7 -Selective Reductive Amination of an Unprotected Pyrazole Starting Material and Intramolecular Urea Formation with 1,1′-Carbonyl-di(1,2,4-triazol) (CDT)

An Enzymatic Method to Obtain Enantiopure 3‐Pyridyl and Substituted Phenyl Alanine

Convenient synthesis of (S)-alpha,alpha'-diphenyl-2-pyrrolidinemethanol